⌘K

Login Start Free

Home/Filings/4/0001104659-23-115375

4//SEC Filing

MCCANN JOE A. 4

Accession 0001104659-23-115375

CIK 0001811764other

View on SEC.gov Company Profile

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 6:33 PM ET

Size

5.4 KB

Accession

0001104659-23-115375

Insider Transaction Report

Form 4

Period: 2023-11-06

POINT Biopharma Global Inc.PNT

DirectorChief Executive Officer

Transactions

Gift
Common Stock
2023-11-06−120,000→ 3,494,153 total(indirect: Personal Holding Company)

Holdings

Common Stock
2,160

Footnotes (1)

[F1]Reflects the gift of common stock to a charitable donor-advised fund.

Documents

1 file

4
tm2330145-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

POINT Biopharma Global Inc.

CIK 0001811764

Entity typeother

Related Parties

1

filerCIK 0001868644

Filing Metadata

Form type: 4
Filed: Nov 6, 7:00 PM ET
Accepted: Nov 7, 6:33 PM ET
Size: 5.4 KB

View on SEC.gov